Amos Grünebaum: The Cost of Ideology in Fertility Treatments
Amos Grünebaum, Professor of Obstetrics and Gynecology Donald and Barbara Zucker School of Medicine, shared at on LinkedIn:
“IVF, ‘Natural’ Medicine, and the Cost of Ideology
When fertility care is framed as a moral project rather than a medical one, patients pay the price. A new JAMA Viewpoint examines how so-called ‘restorative reproductive medicine’ restricts access to IVF and other evidence-based treatments, not because they are unsafe, but because they conflict with ideology. In this piece, I unpack why denying effective care in the name of ‘natural’ medicine is neither ethical nor patient-centered, and why this debate matters far beyond infertility clinics.
More here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 29, 2026, 15:58Eric Lameignere: Can DNA Fragmentation in Cumulus Cells Predict ICSI Outcomes?
-
Oct 29, 2026, 15:50Saadat Hassan: Sperm Function Testing – Can Advanced Diagnostics Guide IVF and ICSI Selection?
-
Oct 29, 2026, 15:34Sara Spiro: Celebrating the Stories Members Have Trusted With at Maven Clinic – Here Is Mine
-
Oct 29, 2026, 15:31Dina Ibrahem: 0 Motility, 1 Critical Decision
-
Oct 29, 2026, 15:28AI and Automation in Fertility and Genomics: Pipeline or Pipe Dream? – ARCS
-
Oct 29, 2026, 15:26Michael Schindler: Large Networks or Small Centers – Who Delivers Better Care?
-
Oct 29, 2026, 15:24Denny Sakkas: Driving Innovation in Reproductive Medicine
-
Oct 29, 2026, 15:10From the President’s Gala to Booth 905 at ASRM 2026 – First Fertility
-
Oct 29, 2026, 15:04Proud to Spotlight Dr. Jannie Michielsen and the Expertise She Brings to Every Day – Sims IVF